This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thio, C. L.
Right arrow Articles by Thomas, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thio, C. L.
Right arrow Articles by Thomas, D. L.

 Previous Article  |  Next Article 

Journal of Virology, July 2005, p. 9192-9196, Vol. 79, No. 14
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.14.9192-9196.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Mannose Binding Lectin Genotypes Influence Recovery from Hepatitis B Virus Infection

Chloe L. Thio,1* Timothy Mosbruger,1 Jacquie Astemborski,1 Spencer Greer,1 Gregory D. Kirk,2 Stephen J. O'Brien,3 and David L. Thomas1

Departments of Medicine,1 Epidemiology, Johns Hopkins University, Baltimore, Maryland,2 Laboratory of Genomic Diversity, National Cancer Institute, Frederick, Maryland3

Received 22 February 2005/ Accepted 14 March 2005

Mannose binding lectin (MBL) is a central component of the innate immune response and thus may be important for determining hepatitis B virus (HBV) persistence. Since single-nucleotide polymorphisms (SNPs) in the gene encoding MBL (mbl2) alter the level of functional MBL, we hypothesized that mbl2 genotypes are a determinant of HBV persistence or recovery from viral infection. We tested this hypothesis by using a nested case control design with 189 persons with HBV persistence matched to 338 individuals who had naturally recovered from HBV infection. We determined genotypes of two promoter and three exon 1 SNPs in mbl2 and grouped these genotypes according to the amount of functional MBL production. We found that the promoter SNP –221C, which leads to deficient MBL production, was more common in those subjects with viral persistence (odds ratio [OR], 1.38; 95% confidence interval [CI], 1.01 to 1.89; P = 0.04). Those subjects homozygous for the combination of promoter and exon 1 genotypes associated with the highest amount of functional MBL had significantly increased odds of recovery from infection (OR, 0.55; 95% CI, 0.37 to 0.84; P = 0.005). Conversely, those homozygous for the combination of promoter and exon 1 genotypes which produce the lowest amount of functional MBL were more likely to have viral persistence (OR, 1.76; 95% CI, 1.02 to 3.01; P = 0.04). These data are consistent with the hypothesis that functional MBL plays a central role in the pathogenesis of acute hepatitis B.


* Corresponding author. Mailing address: 1503 E. Jefferson Street, Baltimore, MD 21231. Phone: (410) 955-0349. Fax: (410) 614-7564. E-mail: cthio{at}jhmi.edu.


Journal of Virology, July 2005, p. 9192-9196, Vol. 79, No. 14
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.14.9192-9196.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Maenz, C., Loscher, C., Iwanski, A., Bruns, M. (2008). Inhibition of duck hepatitis B virus infection of liver cells by combined treatment with viral e antigen and carbohydrates. J. Gen. Virol. 89: 3016-3026 [Abstract] [Full Text]  
  • Thio, C. L., Astemborski, J., Bashirova, A., Mosbruger, T., Greer, S., Witt, M. D., Goedert, J. J., Hilgartner, M., Majeske, A., O'Brien, S. J., Thomas, D. L., Carrington, M. (2007). Genetic Protection against Hepatitis B Virus Conferred by CCR5{Delta}32: Evidence that CCR5 Contributes to Viral Persistence. J. Virol. 81: 441-445 [Abstract] [Full Text]  
  • Mehlhop, E., Diamond, M. S. (2006). Protective immune responses against West Nile virus are primed by distinct complement activation pathways. JEM 203: 1371-1381 [Abstract] [Full Text]